Samsung is working hard to make its smartwatch lineup a better alternative to the likes of Apple Watch, and this weekend the company made a huge step in this regard.
The electrocardiogram monitoring, or ECG, feature of the Galaxy Watch Active2 has officially received clearance from the South Korea Ministry of Food and Drug Safety, only a month after the government also approved the blood pressure measurement on the device.
So right now, the Galaxy Watch Active2 has a new pair of health features that make it one of the most advanced smartwatches on the market.
Needless to say, this doesn’t necessarily mean we’ll be getting these new capabilities right away. Samsung says the Health Monitor app, which will include ECG and blood pressure readings, will land in the third quarter of the year.